KURIYEL RALF — SEC Form 4 filings
SEC reporting owner CIK 1733143. 14 Form 4 filings on record with FilingPulse; latest filed 2026-03-23.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-29 to 2026-03-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 15,130 shares, $2,560,081 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 6,973 shares @ $159.36 ($1,111,217) in REPLIGEN CORP, filed 2024-08-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REPLIGEN CORP (RGEN) | Senior VP, R&D | 14 | — | 4 legs · 15,130 sh · $2,560,081 | 22 |
Form 4 filings — KURIYEL RALF
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-23 | 4 | REPLIGEN CORP (RGEN) | Grant/award (A): 5,284 @ $0 · Grant/award (A): 5,669 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | REPLIGEN CORP (RGEN) | Grant/award (A): 125 @ $0 · Tax withholding (F): 42 @ $125.84 | EDGAR |
| 2026-03-03 | 4 | REPLIGEN CORP (RGEN) | Tax withholding (F): 444 @ $128.73 · Tax withholding (F): 923 @ $124.97 | EDGAR |
| 2025-03-04 | 4 | REPLIGEN CORP (RGEN) | Grant/award (A): 4,826 @ $0 · Tax withholding (F): 386 @ $155.38 · Grant/award (A): 4,542 (derivative) @ $0 | EDGAR |
| 2025-02-28 | 4 | REPLIGEN CORP (RGEN) | Tax withholding (F): 391 @ $156.54 | EDGAR |
| 2025-02-25 | 4 | REPLIGEN CORP (RGEN) | Tax withholding (F): 275 @ $164.74 | EDGAR |
| 2024-08-05 | 4 | REPLIGEN CORP (RGEN) | Sale (S): 6,973 @ $159.36 · Option exercise (M): 175 @ $86.10 · Sale (S): 175 @ $158.85 · Option exercise (M): 175 (derivative) @ $0 | EDGAR |
| 2024-08-01 | 4 | REPLIGEN CORP (RGEN) | Sale (S): 4,465 @ $165.67 | EDGAR |
| 2024-05-15 | 4 | REPLIGEN CORP (RGEN) | Tax withholding (F): 534 @ $163.34 | EDGAR |
| 2024-03-12 | 4 | REPLIGEN CORP (RGEN) | Option exercise (M): 1,271 @ $86.10 · Sale (S): 3,517 @ $193.73 · Option exercise (M): 1,271 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | REPLIGEN CORP (RGEN) | Tax withholding (F): 386 @ $195.72 | EDGAR |
| 2024-03-06 | 4 | REPLIGEN CORP (RGEN) | Tax withholding (F): 135 @ $193.99 | EDGAR |
| 2024-03-04 | 4 | REPLIGEN CORP (RGEN) | Grant/award (A): 404 @ $0 · Tax withholding (F): 453 @ $191.79 | EDGAR |
| 2024-02-29 | 4 | REPLIGEN CORP (RGEN) | Grant/award (A): 3,520 @ $0 · Grant/award (A): 3,497 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1733143 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →